Johnson & Johnson (JNJ) FY2026 YTD Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2025-12-29 to 2026-06-28

Swipe to see the full flow
Johnson & Johnson cash flow reconciliation, Dec 29, 2025 through Jun 28, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net earnings → Net cash from operating activities: $10,769,000,000.00Depreciation and amortization of property and intangibles → Operating adjustments reconciliation: $3,963,000,000.00Decrease/(Increase) in other current and non-current assets → Operating adjustments reconciliation: $1,299,000,000.00Stock based compensation → Operating adjustments reconciliation: $758,000,000.00Asset write-downs → Operating adjustments reconciliation: $220,000,000.00Charges for acquired in-process research and development assets → Operating adjustments reconciliation: $2,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $361,000,000.00Operating adjustments reconciliation → Increase in accounts receivable: $1,947,000,000.00Operating adjustments reconciliation → Decrease in other current and non-current liabilities: $1,601,000,000.00Operating adjustments reconciliation → Increase in inventories: $1,002,000,000.00Operating adjustments reconciliation → Decrease in accounts payable and accrued liabilities: $956,000,000.00Operating adjustments reconciliation → Deferred tax provision: $320,000,000.00Operating adjustments reconciliation → Net loss/(gain) on sale of assets/businesses: $43,000,000.00Operating adjustments reconciliation → Credit losses and accounts receivable allowances: $12,000,000.00Credit support agreements activity, net → investing reconciliation: $515,000,000.00Sales of investments → investing reconciliation: $368,000,000.00Proceeds from the disposal of assets/businesses, net (Note 10) → investing reconciliation: $92,000,000.00investing reconciliation → Additions to property, plant and equipment: $2,370,000,000.00investing reconciliation → Purchases of investments: $299,000,000.00investing reconciliation → Acquisitions, net of cash acquired (Note 10): $263,000,000.00investing reconciliation → Other (including capitalized licenses and milestones): $193,000,000.00Net cash used in financing activities → financing reconciliation: $8,247,000,000.00Proceeds from short-term debt, net → financing reconciliation: $13,146,000,000.00Proceeds from the exercise of stock options/employee withholding tax on stock awards, net → financing reconciliation: $1,531,000,000.00financing reconciliation → Repayment of short-term debt, net: $9,677,000,000.00financing reconciliation → Dividends to shareholders: $6,358,000,000.00financing reconciliation → Repurchase of common stock: $4,249,000,000.00financing reconciliation → Repayment of long-term debt: $2,003,000,000.00financing reconciliation → Other: $588,000,000.00financing reconciliation → Credit support agreements activity, net: $49,000,000.00Net cash used in investing activities → investing reconciliation: $2,150,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $19,709,000,000.00Net cash from operating activities → Cash sources and uses: $11,130,000,000.00Cash sources and uses → Exchange-rate effect: $20,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $20,422,000,000.00Cash sources and uses → Net cash used in investing activities: $2,150,000,000.00Cash sources and uses → Net cash used in financing activities: $8,247,000,000.00Net earnings: $10,769,000,000.00Net earnings+$10.77 BDepreciation and amortization of property and intangibles: $3,963,000,000.00Depreciation & amortization+$3.96 BStock based compensation: $758,000,000.00Stock-based compensation+$758.00 MAsset write-downs: $220,000,000.00Asset impairments+$220.00 MNet loss/(gain) on sale of assets/businesses: -$43,000,000.00Asset sales & impairments−$43.00 MDeferred tax provision: -$320,000,000.00Deferred income taxes−$320.00 MCredit losses and accounts receivable allowances: -$12,000,000.00Credit loss provision−$12.00 MIncrease in accounts receivable: -$1,947,000,000.00Accounts receivable−$1.95 BIncrease in inventories: -$1,002,000,000.00Inventories−$1.00 BDecrease in accounts payable and accrued liabilities: -$956,000,000.00Payables & accrued liabilities−$956.00 MDecrease/(Increase) in other current and non-current assets: $1,299,000,000.00Other operating assets+$1.30 BDecrease in other current and non-current liabilities: -$1,601,000,000.00Other operating liabilities−$1.60 BCharges for acquired in-process research and development assets: $2,000,000.00Acquired in-process R&D charges+$2.00 MNet cash from operating activities: $11,130,000,000.00Operating cash+$11.13 BOperating adjustments reconciliation: $6,242,000,000.00Dividends to shareholders: -$6,358,000,000.00Ordinary dividends paid−$6.36 BRepurchase of common stock: -$4,249,000,000.00Common stock repurchases−$4.25 BProceeds from short-term debt, net: $13,146,000,000.00Short-term debt issued+$13.15 BRepayment of short-term debt, net: -$9,677,000,000.00Short-term debt repaid−$9.68 BProceeds from long-term debt, net of issuance costs: $0.00Repayment of long-term debt: -$2,003,000,000.00Senior debt repaid−$2.00 BProceeds from the exercise of stock options/employee withholding tax on stock awards, net: $1,531,000,000.00Option & withholding tax, net+$1.53 BCredit support agreements activity, net: -$49,000,000.00Credit support activity, net−$49.00 MOther: -$588,000,000.00Other financing, net−$588.00 MNet cash used in financing activities: -$8,247,000,000.00. Cash required to fund net payments.Financing cash−$8.25 Bfinancing reconciliation: $22,924,000,000.00Additions to property, plant and equipment: -$2,370,000,000.00PP&E purchases−$2.37 BProceeds from the disposal of assets/businesses, net (Note 10): $92,000,000.00Asset sales+$92.00 MAcquisitions, net of cash acquired (Note 10): -$263,000,000.00Acquisitions, net of cash−$263.00 MAcquired in-process research and development assets / related milestones (Note 10): $0.00Purchases of investments: -$299,000,000.00Investment purchases−$299.00 MSales of investments: $368,000,000.00Investment sales & maturities+$368.00 MCredit support agreements activity, net: $515,000,000.00Credit support activity, net+$515.00 MOther (including capitalized licenses and milestones): -$193,000,000.00Other investing, net−$193.00 MNet cash used in investing activities: -$2,150,000,000.00. Cash required to fund net payments.Investing cash−$2.15 Binvesting reconciliation: $3,125,000,000.00Cash sources and uses: $30,839,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $19,709,000,000.00Beginning cash$19.71 BEnding cash: Cash, cash equivalents, and restricted cash: $20,422,000,000.00Ending cash$20.42 BExchange-rate effect: -$20,000,000.00FX effect−$20.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$8.76 BOperating cash − cash spent on PP&ECash flow / Net income1.03×Operating cash flow ÷ net incomeNet cash change+$713.00 MEnding cash − beginning cash
Chart details

Johnson & Johnson cash flow reconciliation, Dec 29, 2025 through Jun 28, 2026

Cash flows for Dec 29, 2025 through Jun 28, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 28, 2025. Ending cash: Jun 28, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 28, 2025
19,709,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
11,130,000,000 US dollars. Net cash provided.
Net earnings
10,769,000,000 US dollars
Depreciation and amortization of property and intangibles
3,963,000,000 US dollars
Stock based compensation
758,000,000 US dollars
Asset write-downs
220,000,000 US dollars
Net loss/(gain) on sale of assets/businesses
negative 43,000,000 US dollars
Deferred tax provision
negative 320,000,000 US dollars
Credit losses and accounts receivable allowances
negative 12,000,000 US dollars
Increase in accounts receivable
negative 1,947,000,000 US dollars
Increase in inventories
negative 1,002,000,000 US dollars
Decrease in accounts payable and accrued liabilities
negative 956,000,000 US dollars
Decrease/(Increase) in other current and non-current assets
1,299,000,000 US dollars
Decrease in other current and non-current liabilities
negative 1,601,000,000 US dollars
Charges for acquired in-process research and development assets
2,000,000 US dollars
Investing activities
negative 2,150,000,000 US dollars. Net cash used.
Additions to property, plant and equipment
negative 2,370,000,000 US dollars
Proceeds from the disposal of assets/businesses, net (Note 10)
92,000,000 US dollars
Acquisitions, net of cash acquired (Note 10)
negative 263,000,000 US dollars
Acquired in-process research and development assets / related milestones (Note 10)
0 US dollars
Purchases of investments
negative 299,000,000 US dollars
Sales of investments
368,000,000 US dollars
Credit support agreements activity, net
515,000,000 US dollars
Other (including capitalized licenses and milestones)
negative 193,000,000 US dollars
Financing activities
negative 8,247,000,000 US dollars. Net cash used.
Dividends to shareholders
negative 6,358,000,000 US dollars
Repurchase of common stock
negative 4,249,000,000 US dollars
Proceeds from short-term debt, net
13,146,000,000 US dollars
Repayment of short-term debt, net
negative 9,677,000,000 US dollars
Proceeds from long-term debt, net of issuance costs
0 US dollars
Repayment of long-term debt
negative 2,003,000,000 US dollars
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net
1,531,000,000 US dollars
Credit support agreements activity, net
negative 49,000,000 US dollars
Other
negative 588,000,000 US dollars
Operating adjustment reconciliation
6,242,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
22,924,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
3,125,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 20,000,000 US dollars
Ending cash on Jun 28, 2026
20,422,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
30,839,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
713,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.03×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
11,130,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
2,370,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
8,760,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $361.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 11,130,000,000 US dollars minus 2,370,000,000 US dollars equals 8,760,000,000 US dollars.
Johnson & Johnson (JNJ) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!